Table 1

Impact of TTP on cell viability of Colo-357 in vitro using Annexin-V-FITC/DAPI
treatment 1h 24h 48h 72h
control 15.2% (+/−2.8%) 19.3% (+/−1.8%) 30.0% (+/−3.9%) 30.1% (+/−4.4%)
argon gas 12.5% (+/−1.6%) 20.0% (+/−3.9%) 31.7% (+/−3.4%) 33.0% (+/−4.0%)
5s plasma 14.1% (+/−3.4%) 44.7% (+/−7.5%)** 42.9% (+/−3.9%)** 49.0% (+/−5.9%)**
10s plasma 10.5% (+/−4.7%) 50.3% (+/−2.4%)** 50.3% (+/−5.4%)** 59.0% (+/−7.0%)**
20s plasma 14.2% (+/−5.8%) 69.4% (+/−16.7%)** 73.7% (+/−6.5%)** 78.0% (+/−9.6%)**

** Indicates significant difference compared to controls (P< 0.01).

Partecke et al.

Partecke et al. BMC Cancer 2012 12:473   doi:10.1186/1471-2407-12-473

Open Data